Energy Balance Modulates Mouse Skin Tumor Promotion Through Altered IGF-1R and EGFR Crosstalk
Overview
Affiliations
Obesity, an established risk factor for epithelial cancers, remains prevalent in the United States and many other countries. In contrast to positive energy balance states (overweight, obesity), calorie restriction (CR) has been shown to act as a universal inhibitor of tumorigenesis in multiple animal models of human cancer. Unfortunately, the mechanisms underlying the enhancing effects of obesity or the inhibitory effects of CR on cancer etiology remain elusive. Here, we evaluated the impact of dietary energy balance manipulation on epithelial carcinogenesis and identified several potential mechanisms that may account for the differential effects of obesity and CR on cancer. Obesity enhanced tumor promotion during epithelial carcinogenesis, in part, due to altered insulin-like growth factor-1 receptor (IGF-1R)/EGF receptor (EGFR) crosstalk and downstream signaling to effectors such as Akt/mTOR. Obesity-induced changes in cellular signaling subsequently led to altered levels of cell-cycle proteins that favored enhanced epidermal proliferation during tumor promotion. In contrast, CR reduced susceptibility to tumor promotion, attenuated IGF-1R/EGFR crosstalk and downstream signaling, and altered levels of cell-cycle proteins that favored reduced epidermal proliferation during tumor promotion. Collectively, these findings suggest potential targets for the prevention of epithelial cancers, as well as for reversal of obesity-mediated cancer development and progression. Cancer Prev Res; 5(10); 1236-46. ©2012 AACR.
Saha A, Hamilton-Reeves J, DiGiovanni J Cancer Metastasis Rev. 2022; 41(3):649-671.
PMID: 35927363 PMC: 9474694. DOI: 10.1007/s10555-022-10056-0.
The Role of Diet in Cancer Prevention and Chemotherapy Efficacy.
Mittelman S Annu Rev Nutr. 2020; 40:273-297.
PMID: 32543948 PMC: 8546934. DOI: 10.1146/annurev-nutr-013120-041149.
Ayoub N, Yaghan R, Abdo N, Matalka I, Akhu-Zaheya L, Al-Mohtaseb A J Obes. 2019; 2019:3820759.
PMID: 31019808 PMC: 6452538. DOI: 10.1155/2019/3820759.
Bragazzi N, Sellami M, Salem I, Conic R, Kimak M, Pigatto P Nutrients. 2019; 11(2).
PMID: 30678053 PMC: 6413166. DOI: 10.3390/nu11020249.
Ayoub N, Alkhatatbeh M, Jibreel M, Ababneh M Oncol Lett. 2017; 13(3):1974-1982.
PMID: 28454352 PMC: 5403199. DOI: 10.3892/ol.2017.5670.